117 HR 5719 IH: Transparency in COVID–19 Vaccination Act U.S. House of Representatives 2021-10-25 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

I117th CONGRESS1st SessionH. R. 5719IN THE HOUSE OF REPRESENTATIVESOctober 25, 2021Mr. Perry (for himself and Mr. Duncan) introduced the following bill; which was referred to the Committee on Energy and CommerceA BILLTo require the Secretary of Health and Human Services to publicly disclose information regarding adverse effects of COVID–19 vaccines.

1.

Short title

This Act may be cited as the Transparency in COVID–19 Vaccination Act.

2.

Public disclosure regarding COVID–19 vaccines

The Secretary of Health and Human Services shall disclose to the public—(1)all adverse events that have arisen from administration of COVID–19 vaccines;(2)an outline of the statistical occurrence and likelihood of adverse events from administration of such vaccines; and(3)information concerning adverse effects of such vaccines taken from findings of clinical trials or other studies.